Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02018861 |
Title | A Phase 1, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 Monotherapy and in Combination With INCB039110 in Subjects With Previously Treated B-Cell Malignancies |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Incyte Corporation |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama At Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35205 | United States | Details | |
University of Michigan Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Nyu Langone Laura and Isaac Perlmutter Cancer Center | New York | New York | 10016 | United States | Details | |
University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | United States | Details | |
Greenville Health System Cancer Institute | Greenville | South Carolina | 29605 | United States | Details | |
Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | United States | Details |